Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product

Biochemical and Biophysical Research Communications

Volumn 275, Issue 3, 2000, Pages 877-884

  Soni, Rajeev ^a   Muller, Lionel ^a   Furet, Pascal ^a   Schoepfer, Joseph ^a   Stephan, Christine ^a   Zumstein Mecker, Sabine ^a   Fretz, Heinz ^a   Chaudhuri, Bhabatosh ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cdk4; Cell cycle; Fascaplysin; G1 arrest; Inhibition; p16; pRb

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; FASCAPLYSIN; NATURAL PRODUCT;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MARINE ENVIRONMENT; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0034618674     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3349     Document Type: Article

References (52)

1. Four-dimensional control of the cell cycle
2. Mechanisms of cyclin-dependent kinase regulation: Structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors
3. Cyclin dependent kinases: Engines, clocks and microprocessors
4. Inhibitors of mammalian G1 cyclin-dependent kinases
5. The retinoblastoma protein pathway and the restriction point
6. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
7. The retinoblastoma protein and cell cycle control
8. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2
9. Defining the substrate specificity of cdk4 kinase-cyclin D1 complex
10. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation
11. The regulation of E2F by pRB-family proteins
12. Retinoblastoma protein dependent cell-cycle inhibition by the tumour suppressor p16
13. The INK4a/ARF tumor suppressor: One gene-two products-two pathways
14. Perturbation of cell cycle regulators in human cancer
15. Mutations and altered expression of p16(INK4A) in human cancer
16. Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas
17. Cyclin D1 as a cellular protooncogene
18. Effects of exogenous p16INK4a on growth of cells with various status of cell-cycle regulators
19. Growth suppression by p16(INK4A) requires functional retinoblastoma protein
20. Reciprocal Rb inactivation and p16(INK4A) expression in primary lung cancers and cell lines
21. Chemical inhibitors of cyclin-dependent kinases
22. Exploiting chemical libraries, structure, and genomics in the search for new kinase inhibitors
23. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases
24. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
25. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
26. Characterization of novel inhibitors of cyclin-dependent kinases
27. Fascaplysin, an unusual antimicrobial pigment from the marine sponge Fascaplysinopsis sp
28. A simple and practical approach to the synthesis of the marine sponge pigment fascaplysin and related compounds
29. Total syntheses of the marine sponge pigments fascaplysin and homofascaplysin B and C
30. DNA binding protein dbpA binds Cdk5 and inhibit its activity
31. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase
32. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4
33. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2
34. D-type cyclin-dependent kinase activity in mammalian cells
35. Inhibition of cyclin-dependent kinases by p21
36. Assay for activity of mammalian cyclin D-dependent kinases CDK4 and CDK6
37. Novel Cdk inhibitors restore TGF-β sensitivity in Cdk4 over-expressing epithelial cells
38. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation
39. Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agent
40. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex
41. Undersulfation of proteoheparan sulfate stimulates the expression of basic fibroblast growth factor and protein synthesis but suppresses replication of coronary smooth muscle cells
42. Cell cycle start from quiescence controlled by tyrosine phosphorylation of Cdk4
43. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics
44. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein
45. The retinoblastoma tumor suppressor protein
46. Mutational effects on the p16INK4a tumor suppressor protein
47. Tumor suppressor p16INK4A: Determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4
48. Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A
49. The effects of transferring tumor suppressor gene p16INK4A to p16INK4A-deleted cancer cells
50. The inhibitory effect of adenovirus-mediated p16INK4a gene transfer on the proliferation of lung cancer cell line
51. Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1
52. Transfection of an inducible p16/CDKN2A construct mediates reversible growth inhibition and G1 arrest in the AtT20 pituitary tumor cell line